MorphoSys

About:

MorphoSys is a biotechnology company focused on the research and development of fully human antibodies.

Website: http://www.morphosys.com

Twitter/X: MorphoSys

Top Investors: Atlas Venture

Description:

MorphoSys AG is a biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next generation of antibodies, which can be used to treat diseases and for research and diagnostics purposes. Numerous partnerships have already been entered into with well-known companies from the pharmaceutical and biotechnology sectors, such as Boehringer Ingelheim, Daiichi Sankyo, Merck & Co, Novartis, Pfizer, and Roche.

Total Funding Amount:

$748M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Planegg, Bayern, Germany

Founded Date:

1992-01-01

Contact Email:

info(AT)morphosys.com

Founders:

Andreas Pluckthun, Simon E. Moroney

Number of Employees:

501-1000

Last Funding Date:

2023-12-14

IPO Status:

Public

© 2025 bioDAO.ai